Co-Chair’s Opening Remarks and Recap of Day One
September 15, 2016 • 8:15 am
From Glofish to Frankenfish: Understanding How the Approval of Transgenic Animals May Impact Animal and Human Food and Drugs
September 14, 2016 • 9:30 am
Safe Guards for Third Party Clinical Studies in the Animal Health Arena
September 15, 2016 • 11:15 am
Animal Biologic Development: The Continuing Debate Between Cure and Cost
September 14, 2016 • 1:45 pm
Non-Economic Damages for Animal Loss: Assessing the Legalities, Realities as well as Economic Consequences of Such Awards for the Animal Health Industry
September 14, 2016 • 1:00 pm
Exploring the Continuing Controversy of Antibiotic Use in Livestock
September 14, 2016 • 10:30 am
Revisiting the Animal Drug Compounding Debate
September 15, 2016 • 9:15 am
Exploring New Controversies in Bioequivalency Studies for Animal Drugs
September 15, 2016 • 10:30 am
New Considerations for Advertising and Promotion of Animal Drugs and Animal Foods
September 14, 2016 • 4:15 pm
Establishing Protocols for The Next Wave of FSMA Rule Implementation for Animal Feed, Pet Food and Animal Drug Manufacturers
September 14, 2016 • 11:15 am
Pet Prescription Portability: An In-Depth Look at the Proposed Fairness to Pet Owner Act
September 15, 2016 • 8:30 am
FDA Enforcement Activity in the Animal Health Industry: A Year In Review
September 14, 2016 • 8:45 am
Dietary Supplements for Animals: Cause and Controversy
September 14, 2016 • 2:45 pm
Receive exclusive discounts, offers and agenda updates directly to your inbox.